Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05235867 · ClinicalTrials.gov registry record
Secretin in Refeeding
A clinical trial of Anorexia in Adolescence, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT05235867: Recruiting study of Anorexia in Adolescence, sponsored by University of California, Los Angeles.
NCT05235867 is a study of Anorexia in Adolescence that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05235867, a study of Anorexia in Adolescence, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.
Primary Outcome
Change in secretin value from pre- to post- meal
Conditions Studied
Study Locations (1)
California
- University of California, Los Angeles (UCLA) - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2027-12-31 |
What NCT05235867 shows while recruiting
NCT05235867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 1 condition, with Anorexia in Adolescence appearing as the primary indexed condition, and to 0 interventions.
NCT05235867 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05235867 about?
NCT05235867 is a clinical study titled "Secretin in Refeeding". Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both ...
What is the current status of trial NCT05235867?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2022-02-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05235867 study?
This clinical trial studies the following conditions: Anorexia in Adolescence.
Who is sponsoring clinical trial NCT05235867?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05235867 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI